-
公开(公告)号：US6022951A
公开(公告)日：2000-02-08
申请号：US628540
申请日：1996-04-10
申请人： Takeshi Sano , Charles R. Cantor , Sandor Vajda , Gabriel O. Reznik , Cassandra L. Smith , Mark W. Pandori
发明人： Takeshi Sano , Charles R. Cantor , Sandor Vajda , Gabriel O. Reznik , Cassandra L. Smith , Mark W. Pandori
IPC分类号： A61K38/00 , C07K14/36 , C12N1/21 , C12N15/31 , G01N33/538
CPC分类号： G01N33/538 , C07K14/36 , A61K38/00 , G01N2333/465 , Y10S530/808 , Y10S530/81
摘要： The present invention relates to streptavidin proteins and peptides having a altered physical properties such as an increased stability or increased or decreased affinity for binding biotin. The invention also relates to methods for the detection, identification, separation and isolation of targets using streptavidin proteins or peptides. Streptavidin with increased or reduced affinity allows for the use of the streptavidin-biotin coupling systems for detection and isolation systems wherein it is necessary to remove of one or the other of the binding partners. Such systems are useful for the purification of functional proteins and viable cells. The invention also relates to nucleic acids which encode these streptavidin proteins and peptides and to recombinant cells such as bacteria, yeast and mammalian cells which contain these nucleic acids.
摘要翻译： 本发明涉及链霉抗生物素蛋白和具有改变的物理性质例如增加的稳定性或增加或降低的结合生物素的亲和力的肽。 本发明还涉及使用链霉亲和素蛋白或肽检测，鉴定，分离和分离靶的方法。 具有增加或降低亲和力的链霉亲和素允许使用链霉抗生物素蛋白 - 生物素偶联系统进行检测和分离系统，其中必须除去一种或另一种结合配偶体。 这样的系统可用于纯化功能性蛋白质和活细胞。 本发明还涉及编码这些链霉抗生物素蛋白和肽以及含有这些核酸的重组细胞如细菌，酵母和哺乳动物细胞的核酸。
-
公开(公告)号：US07319003B2
公开(公告)日：2008-01-15
申请号：US09030571
申请日：1998-02-24
CPC分类号： C12Q1/6874 , B01J19/0046 , B01J2219/00527 , B01J2219/00529 , B01J2219/0059 , B01J2219/00605 , B01J2219/0061 , B01J2219/00612 , B01J2219/00626 , B01J2219/0063 , B01J2219/00637 , B01J2219/00644 , B01J2219/00648 , B01J2219/00659 , B01J2219/00722 , C12Q1/6837 , C40B40/06 , C40B80/00 , C12Q2565/537 , C12Q2525/161 , C12Q2565/515 , C12Q2525/204 , C12Q2521/501
摘要： This invention is directed to methods and reagents useful for sequencing nucleic acid targets utilizing sequencing by hybridization technology comprising probes, arrays of probes and methods whereby sequence information is obtained rapidly and efficiently in discrete packages. That information can be used for the detection, identification, purification and complete or partial sequencing of a particular target nucleic acid. When coupled with a ligation step, these methods can be performed under a single set of hybridization conditions. The invention also relates to the replication of probe arrays and methods for making and replicating arrays of probes which are useful for the large scale manufacture of diagnostic aids used to screen biological samples for specific target sequences. Arrays created using PCR technology may comprise probes with 5′- and/or 3′-overhangs.
摘要翻译： 本发明涉及可用于使用包括探针，探针阵列和方法的杂交技术测序的用于测序核酸靶的方法和试剂，从而在离散包装中快速有效地获得序列信息。 该信息可以用于特定靶核酸的检测，鉴定，纯化和完全或部分测序。 当与连接步骤相结合时，这些方法可以在单一杂交条件下进行。 本发明还涉及探针阵列的复制和用于制备和复制探针阵列的方法，所述探针阵列可用于大规模制造用于筛选特定靶序列的生物样品的诊断辅助物。 使用PCR技术产生的阵列可以包含具有5'和/或3'突出端的探针。
-
3.发明授权公开(公告)号：US06287844B1
公开(公告)日：2001-09-11
申请号：US09019966
申请日：1998-02-06
申请人： Przemyslaw Szafranski , Charlene Mello , Takeshi Sano , Cassandra L. Smith , David L. Kaplan , Charles R. Cantor
发明人： Przemyslaw Szafranski , Charlene Mello , Takeshi Sano , Cassandra L. Smith , David L. Kaplan , Charles R. Cantor
IPC分类号： C12N120
摘要： Compositions and methods for the control of genetically engineered organisms are described. A more effective cell suicide approach is contemplated based on the conditional expression of the lethal Streptomyces avidinii streptavidin gene. Toxicity of streptavidin is derived from its exceptionally high binding affinity for an essential prosthetic group, D-biotin. The general requirement for biotin through the living world makes streptavidin-based conditional lethal designs applicable to a broad range of containment strategies.
摘要翻译： 描述了用于控制转基因生物的组合物和方法。 基于致死性链霉菌链霉亲和素链霉亲和素基因的条件表达考虑了更有效的细胞自杀方法。 链霉抗生物素蛋白的毒性源自其对必需的假基团D-生物素的极高的结合亲和力。 生物素通过生活世界的一般要求使基于链霉亲和素的条件致命设计适用于广泛的遏制策略。
-
公开(公告)号：US5795714A
公开(公告)日：1998-08-18
申请号：US110691
申请日：1993-08-23
CPC分类号： C12Q1/6874 , B01J19/0046 , C12Q1/6837 , C40B80/00 , B01J2219/00527 , B01J2219/00529 , B01J2219/0059 , B01J2219/00605 , B01J2219/0061 , B01J2219/00612 , B01J2219/00626 , B01J2219/0063 , B01J2219/00637 , B01J2219/00644 , B01J2219/00648 , B01J2219/00659 , B01J2219/00722 , C40B40/06
摘要： The invention relates to the replication of probe arrays and methods for replicating arrays of probes which are useful for the large scale manufacture of diagnostic aids used to screen biological samples for specific target sequences. Arrays created using PCR technology may comprise probes with 5'- and/or 3'-overhangs.
摘要翻译： 本发明涉及用于复制探针阵列的探针阵列的复制和可用于大规模制造用于筛选特定靶序列的生物样品的诊断辅助物的方法。 使用PCR技术产生的阵列可以包含具有5'和/或3'突出端的探针。
-
5.发明授权
公开(公告)号：US6124129A
公开(公告)日：2000-09-26
申请号：US19966
申请日：1998-02-06
申请人： Przemyslaw Szafranski , Charlene Mello , Takeshi Sano , Cassandra L. Smith , David L. Kaplan , Charles R. Cantor
发明人： Przemyslaw Szafranski , Charlene Mello , Takeshi Sano , Cassandra L. Smith , David L. Kaplan , Charles R. Cantor
摘要： Compositions and methods for the control of genetically engineered organisms are described. A more effective cell suicide approach is contemplated based on the conditional expression of the lethal Streptomyces avidinii streptavidin gene. Toxicity of streptavidin is derived from its exceptionally high binding affinity for an essential prosthetic group, D-biotin. The general requirement for biotin through the living world makes streptavidin-based conditional lethal designs applicable to a broad range of containment strategies.
摘要翻译： 描述了用于控制转基因生物的组合物和方法。 基于致死性链霉菌链霉亲和素链霉亲和素基因的条件表达考虑了更有效的细胞自杀方法。 链霉抗生物素蛋白的毒性源自其对必需的假基团D-生物素的极高的结合亲和力。 生物素通过生活世界的一般要求使基于链霉亲和素的条件致命设计适用于广泛的遏制策略。
-
公开(公告)号：US20100255558A1
公开(公告)日：2010-10-07
申请号：US12435665
申请日：2009-05-05
CPC分类号： B82Y5/00 , A61K47/54 , A61K47/55 , A61K47/557 , A61K47/6949 , A61K51/1268 , C03C17/30 , C03C17/3405 , C12Q1/6804 , C12Q1/682
摘要： The invention relates to supramolecular bioconjugates and to methods for assembling and utilizing supramolecular bioconjugates. Supramolecular bioconjugates comprise a plurality of first nucleic acids and a plurality of mediators wherein each mediator comprises a second nucleic acid complementary to a sequence within said plurality of first nucleic acids. To assemble a supramolecular bioconjugate, one or more sets of bioreactive agents are coupled to the plurality of mediators, forming a plurality of bioreactive complexes. The plurality of bioreactive complexes are hybridized to the plurality of first nucleic acids to form the supramolecular bioconjugate. Bioconjugates can be used to detect and isolate targets, to screen samples for targets such as antigens, to treat patients with multiple agents or to diagnose disorders in the form of a kit.
摘要翻译： 本发明涉及超分子生物缀合物和组分和利用超分子生物缀合物的方法。 超分子生物缀合物包含多个第一核酸和多个介体，其中每个介体包含与所述多个第一核酸内的序列互补的第二核酸。 为了组装超分子生物缀合物，将一组或多组生物反应剂偶联至多个介体，形成多个生物反应性复合物。 多个生物反应性复合物与多个第一核酸杂交以形成超分子生物缀合物。 生物共轭物可用于检测和分离靶标，筛选靶标如抗原的样品，以治疗患有多种药物的患者或以试剂盒的形式诊断疾病。
-
公开(公告)号：US5679533A
公开(公告)日：1997-10-21
申请号：US479390
申请日：1995-06-07
申请人： Przemyslaw Szafranski , Charlene M. Mello , Takeshi Sano , Kenneth A. Marx , Charles R. Cantor , David L. Kaplan , Cassandra L. Smith
发明人： Przemyslaw Szafranski , Charlene M. Mello , Takeshi Sano , Kenneth A. Marx , Charles R. Cantor , David L. Kaplan , Cassandra L. Smith
CPC分类号： C12N15/70 , C07K14/36 , C07K14/465
摘要： The present invention relates to genetic containment systems which express a biotin-binding component that can be used for selectively destroying recombinant cells such as genetically engineered microorganisms. These systems may comprise a streptavidin or an avidin gene whose expression is controlled by a regulatable promoter. The regulatory agent such as a transcriptional effector is expressed from another gene which may also be expressed and its expression controlled by the containment system. Expression of the agent can be designed to respond to physiological changes in the environment. The invention also relates to containment systems and methods for the selective detection or tracking of recombinant cells and to eukaryotic and prokaryotic cells which contain these genetic containment systems.
-
公开(公告)号：US5665539A
公开(公告)日：1997-09-09
申请号：US131301
申请日：1993-10-04
摘要： A novel system and method for sensitive antigen detection. The system utilizes immuno-polymerase chain reaction in which a specific biotinylated nucleic acid molecule is used as the marker. The biotinylated marker is attached to antigen-antibody complex through a streptavidin-protein A chimeric protein that possesses tight and specific binding affinity both for biotin and immunoglobulin G. A segment of the attached biotinylated marker is amplified by polymerase chain reactions with appropriate primers and the polymerase chain reaction products are detected by agarose gel electrophoresis. The method can detect any antigen and has a greater sensitivity than any existing antigen detection system.
摘要翻译： 一种用于敏感抗原检测的新型系统和方法。 该系统利用免疫聚合酶链反应，其中使用特异性生物素化的核酸分子作为标记。 生物素标记通过链霉抗生物素蛋白 - 蛋白A嵌合蛋白连接到抗原 - 抗体复合物上，该嵌合蛋白对于生物素和免疫球蛋白G都具有紧密和特异性的结合亲和力。通过与适当引物的聚合酶链反应扩增连接的生物素标记的片段，并且 通过琼脂糖凝胶电泳检测聚合酶链反应产物。 该方法可以检测任何抗原并且比任何现有的抗原检测系统具有更高的灵敏度。
-
公开(公告)号：US5561043A
公开(公告)日：1996-10-01
申请号：US189448
申请日：1994-01-31
申请人： Charles R. Cantor , Christof M. Niemeyer , Cassandra L. Smith , Takeshi Sano , Donald J. Hnatowich , Mary Rusckowski
发明人： Charles R. Cantor , Christof M. Niemeyer , Cassandra L. Smith , Takeshi Sano , Donald J. Hnatowich , Mary Rusckowski
IPC分类号： G01N33/566 , A61K38/00 , A61K38/16 , A61K38/21 , A61K38/22 , A61K38/27 , A61K38/43 , A61K39/00 , A61K39/395 , A61K45/00 , A61K47/48 , A61K49/00 , A61K51/00 , A61K51/12 , A61P31/04 , A61P31/12 , A61P35/00 , A61P35/02 , C03C17/30 , C03C17/34 , C07H21/04 , C12N15/09 , C12Q1/68 , C07H21/02
CPC分类号： B82Y5/00 , A61K47/481 , A61K47/48146 , A61K47/48961 , A61K51/1268 , C03C17/30 , C03C17/3405 , C12Q1/6804 , C12Q1/682 , Y10S977/80 , Y10S977/808 , Y10S977/898 , Y10S977/906 , Y10S977/92
摘要： The invention is directed to constructs and compositions containing multimeric forms of nucleic acid. Multimeric nucleic acids comprise single-stranded nucleic acids attached via biotin to streptavidin and bound with a functional group. These constructs can be utilized in vivo to treat or identify diseased tissue or cells. Repeated administrations of multimeric nucleic acid compositions produce a rapid and specific amplification of nucleic acid constructs and their attached functional groups. For treatment purposes, functional groups may be toxins, radioisotopes, genes or enzymes. Diagnostically, labeled multimeric constructs may be used to identify specific targets in vivo or in vitro. Multimeric nucleic acids may also be used in nanotechnology and to create self-assembling polymeric aggregates such as membranes of defined porosity, microcircuits and many other products.
-
公开(公告)号：US07569341B2
公开(公告)日：2009-08-04
申请号：US08967269
申请日：1997-11-07
IPC分类号： C12Q1/68
CPC分类号： B82Y5/00 , A61K47/54 , A61K47/55 , A61K47/557 , A61K47/6949 , A61K51/1268 , C03C17/30 , C03C17/3405 , C12Q1/6804 , C12Q1/682
摘要： The invention relates to supramolecular bioconjugates and to methods for assembling and utilizing supramolecular bioconjugates. Supramolecular bioconjugates comprise a plurality of first nucleic acids and a plurality of mediators wherein each mediator comprises a second nucleic acid complementary to a sequence within said plurality of first nucleic acids. To assemble a supramolecular bioconjugate, one or more sets of bioreactive agents are coupled to the plurality of mediators, forming a plurality of bioreactive complexes The plurality of bioreactive complexes are hybridized to the plurality of first nucleic acids to form the supramolecular bioconjugate. Bioconjugates can be used to detect and isolate targets, to screen samples for targets such as antigens, to treat patients with multiple agents or to diagnose disorders in the form of a kit.
摘要翻译： 本发明涉及超分子生物缀合物和组分和利用超分子生物缀合物的方法。 超分子生物缀合物包含多个第一核酸和多个介体，其中每个介体包含与所述多个第一核酸内的序列互补的第二核酸。 为了组装超分子生物缀合物，将一组或多组生物反应剂偶联到多个介体中，形成多个生物反应性复合物。多个生物反应性复合物与多个第一核酸杂交以形成超分子生物缀合物。 生物共轭物可用于检测和分离靶标，筛选靶标如抗原的样品，以治疗患有多种药物的患者或以试剂盒的形式诊断疾病。
-
-
-
-
-
-
-
-
-
搜索结果
79 条记录 (耗时 0.035 秒)
